Backed by 25 Years of Science and Research
Since 2018, BioXcellerator has been offering cell therapy to treat a wide range of conditions. The latest research shows that mesenchymal stem cells derived from human umbilical cords that we use for treatment can signal the body’s own cells to promote healing, modulate the immune system, control inflammation, and repair damaged tissues.
What are Stem Cells?
Because millions of cells in our bodies die and become damaged each day, they need to be constantly replaced. This is the body’s natural repair process, which is how injuries heal and how we recover from diseases.
All cells—regardless of function—are created from one special type of cell—a stem cell. Through a process called differentiation, a stem cell divides into two cells. That second “daughter” cell can be another stem cell or other type of new cell.
Normally the body has enough stem cells to support the need to generate new cells. But there are various reasons why there may not be enough stem cells available to replace cells needed to promote healing and fight diseases. Cell therapy has attracted the interest of the scientific community because new research and studies show that treatment with various types of cells can help supplement the body to use its own stem cells to improve the regenerative process and promote healing.
How Cell Therapy Works
All cells—regardless of function—are created from stem cells that have the potential to differentiate into specific cells in various organs or tissues through a natural development of growth process.
Indeed, stem cells work as part of the body’s natural “repair team” to replace the many different types of cells in the various structures, organs, and tissues.
At BioXcellerator, we use a special type of perinatal cell, Mesenchymal stem cells that are derived from the Wharton’s Jelly in umbilical cords.
Research shows that these cells are among the most effective at stimulating healing, modulating the immune system, and repairing damaged tissues.
Benefits of Mesenchymal Stem Cells
Based on research by Dr. Arthur Caplan and other noted scientists, Wharton’s jelly mesenchymal stem cells (WJ-MSC) derived from umbilical cords share characteristics that can lead to effective treatment and are ethically sourced.
Cell therapy using mesenchymal stem cells from umbilical cords represents an exciting frontier in the science of medicine. Although these cells do not replace damaged cells in the body, research shows that these cells communicate with other cells—in a sense, “teach” other cells how to function in a way that can help the body heal itself.
Properties of BioXcellerator Mesenchymal Stem Cells
Many clinics procure cells from other labs, but the cells can degrade during shipping. At BioXcellerator, we operate our own on-site lab and cell bank to assure cells meet the highest standards for safety, efficacy, potency, and viability.
Our lab complies with widely accepted international standards and our protocols have been designed based on extensive research into selecting, testing, refining, and purifying cells before they are cultured and expanded into infusions with the highest potential to stimulate healing—our Signature Cells.
Precision Stem Cell Applications
Most patient protocols include at least one intravenous (IV) infusion. For this simple procedure, cells are infused intravenously to allow the cells to circulate throughout the body.
Other treatment protocols include direct injection to specific treatment sites. When appropriate, our physicians take advantage of advanced imaging technology such as X-ray fluoroscopy to precisely guide cells to these sites. Depending on the condition being treated, these injections can include:
Ongoing Research and Innovation
A recent review by (Galderisi et al.) identified that between 2015 and 2020, there were 416 clinical studies registered to study mesenchymal stem cells isolated from bone marrow, umbilical cord, and adipose tissue—to treat multiple diseases. According to the U.S. National Institutes of Health database, 117 of those studies have been completed.
Although there has been a significant increase in the number of studies to demonstrate safety and effectiveness, further studies are still needed to confirm this evidence, validate safety and identify future research opportunities in protocols for isolating cells, culturing and expanding cells, and administering them to patients for treatment.
BioXcellerator is now participating in clinical studies that will contribute to this research so that this promising science can help benefit more patients worldwide.
Why are Treatments Not Available in the US?
Although FDA regulations allow Mesenchymal stem cells to be used for treatment in the U.S., the agency does not currently allow these cells to be cultured and expanded. Meaning patients at U.S. clinics may only receive a few thousand cells.
But cell therapy can be far more effective when tens of millions of cells are administered. This is why many patients travel to BioXcellerator for treatment.